Abstract
We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile laboratory" set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 μl/ml during bypass.
Original language | English |
---|---|
Pages (from-to) | 388-392 |
Number of pages | 5 |
Journal | Anaesthesia and Intensive Care |
Volume | 33 |
Issue number | 3 |
DOIs | |
Publication status | Published - Jun 2005 |
Externally published | Yes |
Keywords
- R-hirudin
- Thrombocytopena: heparin-induced, cardiopulmonary bypass